DEERFIELD, Ill. and OSAKA, Japan, April 14, 2015 /PRNewswire/ — Takeda Pharmaceuticals U.S.A. Inc. and Takeda Pharmaceutical Company Limited, (“Takeda”) today announced that members of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the United States (U.S.) Food and Drug Administration (FDA) convened to review one of the first cardiovascular (CV) outcomes trials (CVOT) […]

An ash tray with cigarette butts is pictured in Hinzenbach, in the Austrian province of Upper Austria, February 5, 2012. Reuters/Lisi Niesner (Reuters) – A group of tobacco companies sued the U.S. Food and Drug Administration on Tuesday over recent guidance they say violates their free-speech rights by mandating pre-approval of labeling changes.   Plaintiffs […]

Health | Wed Apr 15, 2015 2:59am EDT MUMBAI | BY ZEBA SIDDIQUI (Reuters) – India may go to the World Trade Organisation (WTO) if the European Union does not reconsider its decision to suspend the sale of about 700 generic drugs that were approved based on clinical trials by GVK Biosciences Pvt Ltd, the firm’s CEO said. The […]

Frost & Sullivan’s Life Sciences consultants have named seven developmental compounds as the most promising therapeutics to watch in 2015. Puma Biotechnology Inc.’s tyrosine kinase inhibitorneratinib, for extended adjuvant treatment of breast cancer: In its Phase III ExteNET clinical trial, neratinib demonstrated significantly higher disease-free survival rates compared to placebo after adjuvant treatment with Herceptin […]

The global EPO market is expected to reach $11.9 billion by 2020, with promising CAGR of 9.7 percentfrom 2014 to 2020, according to a report by Allied Market Research (alliedmarketresearch.com). Darbepoetin alfa is fastest growing drug class at a CAGR of 12.9 percent during the forecast period, owing to its high potency and minimal side […]